Newsletters

Dr. Josep Maria Ribera Recognised with EHA Clinical Excellence Award

[Josep Carreras Leukemia Research Institute] Dr. Josep Maria Ribera, head of the Acute Lymphoblastic Leukaemia laboratory at the Josep Carreras Leukemia Research Institute, has been awarded the prestigious EHA Clinical Excellence Award 2026.

Human Hematopoietic Stem Cells Remember Inflammatory Stress

[Nature] Investigators developed xenograft inflammation–recovery models and performed single-cell multiomics on xenografted human hematopoietic stem cells.

Sphingosine-1-Phosphate Receptor Modulators Resensitize FLT3-ITD Acute Myeloid Leukemia Cells with NRAS Mutations to FLT3 Inhibitors

[Leukemia] Scientists studied sphingosine-1-phosphate and FLT3 co-targeting to overcome FLT3 inhibitor resistance in NRAS-mutated FLT3-ITD AML cells.

A Novel CD7-Directed Antibody-Drug Conjugate Targeting BCL-XL with Potent Anti-Leukemic Activity in T-Cell Acute Lymphoblastic Leukemia

[Leukemia] Researchers reported the design of a novel anti-hCD7 mAb-based antibody-drug conjugate carrying a BCL-XL-selective inhibitor that circumvents this significant limitation.

Reversible Loss of Hematopoietic Stem Cells Transplant Potency by Chronic Salmonella Infection

[Cell Reports] Scientists showed that chronic Salmonella infection significantly impair stem and progenitor cells of the bone marrow. As early as 14 days post-infection, the transplantation potency of HSC is depleted.

Prognostic Impact of Variant Allele Frequency in Intensively Treated Patients with NPM1-Mutated AML: A PETHEMA Study

[Blood] Researchers analyzed 688 intensively treated NPM1-mutated AML integrating variant allele frequency, mutation order, and clonal architecture inferred by PyClone and ClonEvol.

Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents

[American Journal of Hematology] Investigators conducted a multicenter, retrospective analysis of 66 patients diagnosed with VEXAS syndrome treated with hypomethylating agents or allogeneic HSC transplantation.

Discovery of BEND4 As a Novel Single-Gene Prognostic Marker and Therapeutic Target for Adverse AML

[npj Precision Oncology] The authors used transcriptome analyses of primary AML cohorts and identified BEN domain-containing protein 4 (BEND4) as significantly overexpressed in adverse cytogenetic risk.

Evolving Landscape of Targeted Immunotherapeutic Interventions and CAR-T Therapy for Acute Myeloid Leukemia

[npj Precision Oncology] Scientists provide a comprehensive overview of the evolving landscapes of immunotherapeutic strategies, challenges, and breakthroughs in tackling AML.

OCT4-Driven PER1 Activation Promotes Odontogenic Differentiation in Senescent SCAP Spheres

[International Journal of Oral Science] Researchers demonstrated that the pluripotency regulator octamer-binding transcription factor 4 (OCT4) promoted odontogenic differentiation by activating period circadian regulator 1 (PER1) in replicative senescent stem cells from apical papilla (SCAP) spheres.

Bioprocess Design and Optimization of Extracellular Vesicles Derived from Mesenchymal Stromal Cells

[ACS Nano] Scientists established an analytical toolbox comprising scattering and fluorescence mode nanoparticle tracking analysis, fluorescence-based flow cytometry, and multidetector analytical size-exclusion chromatography.

Multifunctional Inverse Opal Nerve Guidance Conduits Loaded with Mesenchymal Stem Cells for Peripheral Nerve Repair

[ACS Applied Materials & Interfaces] Researchers presented a type of multifunctional inverse opal nerve guidance conduit integrating bone marrow MSCs for peripheral nerve repair.
spot_img